https://www.selleckchem.com/pr....oducts/cathepsin-Inh
38), pneumonia (P=0.33), cholangitis (P=0.38), thrombotic complications (P=1.0, cytomegalovirus infection (P=0.53), Epstein-Barr virus infection (P=0.2 and acute rejection (P=0.26). Simultaneous partial splenectomy during liver transplantation could serve as a feasible alternative to splenectomy in selected patients with severe hypersplenism, which can achieve a satisfactory long-term hematological response, but avoid untoward complications of splenectomy. Simultaneous partial splenectomy during liver transplantation c